Investigating how a specific protein affects muscle disease and fibrosis
Dual-specificity phosphatase action in muscle disease
This study is looking at a protein called MKP5 to see how it affects muscle health and the development of fibrosis, which is a problem in muscle-wasting conditions like muscular dystrophies, and the findings could help create new treatments for these issues.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-11092005 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of a protein called MKP5 in the development of fibrosis in skeletal muscle, which is a significant issue in various muscle-wasting disorders like muscular dystrophies. By studying how MKP5 interacts with other signaling pathways, particularly the TGF-β pathway, the research aims to uncover mechanisms that contribute to muscle damage and fibrosis. The approach includes using mouse models to observe the effects of MKP5 on muscle health and fibrosis development. Patients may benefit from insights gained that could lead to new treatments targeting fibrosis in muscle diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with muscular dystrophies or related muscle-wasting conditions characterized by fibrosis.
Not a fit: Patients with muscle diseases not associated with fibrosis or those without a diagnosis of muscular dystrophy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies that reduce muscle fibrosis and improve muscle function in patients with muscular dystrophies.
How similar studies have performed: Previous research has shown promising results in targeting fibrosis in muscle diseases, suggesting that this approach could yield significant advancements.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Bennett, Anton M — Yale University
- Study coordinator: Bennett, Anton M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.